Table 3.
SHR erythrocyte monounsaturated fatty acid composition (%total fatty acids) following the consumption of diets with a 25:1 ω-6/ω-3 FAR for 6 weeks§
| Dietary Group | ||||||
|---|---|---|---|---|---|---|
| Fatty acid | Structure | AIN-76A | C | CG | PL | SPG |
| Undecenoic | C11:1 | nd | nd | nd | nd | nd |
| Dodecenoic | C12:1 | nd | nd | nd | nd | nd |
| Tridecanoic | C13:1 | nd | nd | nd | nd | nd |
| Myristoleic | C14:1n5 | nd | nd | nd | nd | nd |
| Pentadecenoic | C15:1n5 | 0.58 ± 0.08a | 0.04 ± 0.00b | 0.06 ± 0.00b | 0.06 ± 0.01b | 0.06 ± 0.00b |
| Palmitoleic | C16:1n7 | 0.28 ± 0.05a | 0.14 ± 0.01b | 0.16 ± 0.01b | 0.15 ± 0.02b | 0.10 ± 0.02b |
| Palmitelaidic | C16:1n7t | 0.43 ± 0.04a | 0.41 ± 0.05a | 0.35 ± 0.05a | 0.37 ± 0.04a | 0.56 ± 0.03b |
| Heptadecenoic | C17:1n7 | nd | nd | nd | nd | nd |
| Elaidic | C18:1n9t | nd | nd | nd | nd | nd |
| Vaccenic | C18:1n11c | nd | nd | nd | nd | nd |
| Trans-vaccenic | C18:1n7t | nd | nd | nd | nd | nd |
| Oleic | C18:1n9c | 5.60 ± 0.61a | 9.41 ± 0.33c | 8.56 ± 0.35bc | 8.55 ± 0.25bc | 7.76 ± 0.23b |
| Cis-vaccenic | C18:1n7c | 1.30 ± 0.17a | 1.88 ± 0.08b | 1.71 ± 0.07b | 1.78 ± 0.06b | 2.31 ± 0.09c |
| cis-5 Eicosenoic | C20:1n15 | nd | 0.31 ± 0.04 | nd | nd | nd |
| cis-8-Eicosenoic | C20:1n12 | nd | 0.26 ± 0.03 | nd | nd | nd |
| Eicosenoic | C20:1n9 | 0.07 ± 0.00a | 0.26 ± 0.03b | 0.23 ± 0.04b | 0.19 ± 0.03ab | 0.22 ± 0.02b |
| Erucic | C22:1n9 | nd | nd | nd | nd | nd |
| Nervonic | C24:1n9 | 0.90 ± 0.20a | 2.38 ± 0.23b | 2.03 ± 0.19b | 2.61 ± 0.41b | 4.08 ± 0.40c |
| Total MUFAs | 9.09 ± 1.01 a | 15.10 ± 0.25 c | 13.11 ± 0.35 b | 13.64 ± 0.39 bc | 14.98 ± 0.70 c | |
§Data are (expressed as) mean percentage ± SE. Values in the same row that do not share the same superscript letter are significantly different according to analysis of variance and Duncan’s post hoc procedures (p < .05); nd not detected